Institution
Michigan Department of Community Health
Government•Lansing, Michigan, United States•
About: Michigan Department of Community Health is a government organization based out in Lansing, Michigan, United States. It is known for research contribution in the topics: Population & Public health. The organization has 378 authors who have published 552 publications receiving 30891 citations.
Topics: Population, Public health, Health care, Outbreak, Poison control
Papers published on a yearly basis
Papers
More filters
••
Centers for Disease Control and Prevention1, University of Cambridge2, National Institutes of Health3, Erasmus University Rotterdam4, Naval Medical Center San Diego5, Arizona State University6, Colorado Department of Public Health and Environment7, Oklahoma State Department of Health8, Wadsworth Center9, Ohio Department of Health10, South Carolina Department of Health and Environmental Control11, Dallas County12, Baylor College of Medicine13, San Diego State University14, Centra15, California Health and Human Services Agency16, Marshfield Clinic17, Michigan Department of Community Health18
TL;DR: The lack of similarity between the 2009 A(H1N1) virus and its nearest relatives indicates that its gene segments have been circulating undetected for an extended period as mentioned in this paper.
Abstract: Since its identification in April 2009, an A(H1N1) virus containing a unique combination of gene segments from both North American and Eurasian swine lineages has continued to circulate in humans. The lack of similarity between the 2009 A(H1N1) virus and its nearest relatives indicates that its gene segments have been circulating undetected for an extended period. Its low genetic diversity suggests that the introduction into humans was a single event or multiple events of similar viruses. Molecular markers predictive of adaptation to humans are not currently present in 2009 A(H1N1) viruses, suggesting that previously unrecognized molecular determinants could be responsible for the transmission among humans. Antigenically the viruses are homogeneous and similar to North American swine A(H1N1) viruses but distinct from seasonal human A(H1N1).
2,393 citations
••
Centers for Disease Control and Prevention1, National Center for Immunization and Respiratory Diseases2, California Department of Public Health3, Arizona Department of Health Services4, Michigan Department of Community Health5, Texas Department of State Health Services6, Chicago Department of Public Health7, Massachusetts Department of Public Health8
TL;DR: Cases and deaths associated with pandemic H1N1 virus in pregnant women identified in the USA during the first month of the present outbreak lend support to the present recommendation to promptly treat pregnant women with H 1N1 influenza virus infection with anti-influenza drugs.
1,246 citations
••
National Institutes of Health1, Cancer Prevention Institute of California2, Michigan Department of Community Health3, Connecticut Agricultural Experiment Station4, University of Hawaii at Manoa5, University of Iowa6, Fred Hutchinson Cancer Research Center7, New Jersey Department of Health and Senior Services8, Texas Department of State Health Services9, United States Department of Health and Human Services10
TL;DR: Standardized incidence ratios and excess absolute risks assessing relative and absolute cancer risk in transplant recipients compared with the general population to describe the overall pattern of cancer following solid organ transplantation are described.
Abstract: Context Solid organ transplant recipients have elevated cancer risk due to immunosuppression and oncogenic viral infections. Because most prior research has concerned kidney recipients, large studies that include recipients of differing organs can inform cancer etiology. Objective To describe the overall pattern of cancer following solid organ transplantion. Design, Setting, and Participants Cohort study using linked data on solid organ transplant recipients from the US Scientific Registry of Transplant Recipients (1987-2008) and 13 state and regional cancer registries. Main Outcome Measures Standardized incidence ratios (SIRs) and excess absolute risks (EARs) assessing relative and absolute cancer risk in transplant recipients compared with the general population. Results The registry linkages yielded data on 175 732 solid organ transplants (58.4% for kidney, 21.6% for liver, 10.0% for heart, and 4.0% for lung). The overall cancer risk was elevated with 10 656 cases and an incidence of 1375 per 100 000 person-years (SIR, 2.10 [95% CI, 2.06-2.14]; EAR, 719.3 [95% CI, 693.3-745.6] per 100 000 person-years). Risk was increased for 32 different malignancies, some related to known infections (eg, anal cancer, Kaposi sarcoma) and others unrelated (eg, melanoma, thyroid and lip cancers). The most common malignancies with elevated risk were non-Hodgkin lymphoma (n = 1504; incidence: 194.0 per 100 000 person-years; SIR, 7.54 [95% CI, 7.17-7.93]; EAR, 168.3 [95% CI, 158.6-178.4] per 100 000 person-years) and cancers of the lung (n = 1344; incidence: 173.4 per 100 000 person-years; SIR, 1.97 [95% CI, 1.86-2.08]; EAR, 85.3 [95% CI, 76.2-94.8] per 100 000 person-years), liver (n = 930; incidence: 120.0 per 100 000 person-years; SIR, 11.56 [95% CI, 10.83-12.33]; EAR, 109.6 [95% CI, 102.0-117.6] per 100 000 person-years), and kidney (n = 752; incidence: 97.0 per 100 000 person-years; SIR, 4.65 [95% CI, 4.32-4.99]; EAR, 76.1 [95% CI, 69.3-83.3] per 100 000 person-years). Lung cancer risk was most elevated in lung recipients (SIR, 6.13 [95% CI, 5.18-7.21]) but also increased among other recipients (kidney: SIR, 1.46 [95% CI, 1.34-1.59]; liver: SIR, 1.95 [95% CI, 1.74-2.19]; and heart: SIR, 2.67 [95% CI, 2.40-2.95]). Liver cancer risk was elevated only among liver recipients (SIR, 43.83 [95% CI, 40.90-46.91]), who manifested exceptional risk in the first 6 months (SIR, 508.97 [95% CI, 474.16-545.66]) and a 2-fold excess risk for 10 to 15 years thereafter (SIR, 2.22 [95% CI, 1.57-3.04]). Among kidney recipients, kidney cancer risk was elevated (SIR, 6.66 [95% CI, 6.12-7.23]) and bimodal in onset time. Kidney cancer risk also was increased in liver recipients (SIR, 1.80 [95% CI, 1.40-2.29]) and heart recipients (SIR, 2.90 [95% CI, 2.32-3.59]). Conclusion Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have an increased risk for diverse infection-related and unrelated cancers.
1,147 citations
••
TL;DR: Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers and carried the vanA resistance gene, which may have come from the vancomycius-resistant Enterococcus faecalis that was also isolated from the patient.
Abstract: Vancomycin-resistant S. aureus was cultured from the exit site of a temporary dialysis catheter of a patient with diabetes, peripheral vascular disease, and persistent foot ulcers. The organism carried the vanA resistance gene, which may have come from the vancomycin-resistant Enterococcus faecalis that was also isolated from the patient, who had received vancomycin for several weeks.
1,114 citations
••
TL;DR: Several evidence-based strategies can help reduce excessive drinking and related costs, including increasing alcohol excise taxes, limiting alcohol outlet density, and commercial host liability.
835 citations
Authors
Showing all 379 results
Name | H-index | Papers | Citations |
---|---|---|---|
Mathew J. Reeves | 68 | 272 | 39327 |
Wendy Cozen | 66 | 285 | 18159 |
Patrick L. Remington | 51 | 317 | 10565 |
James M. Pivarnik | 44 | 174 | 10165 |
Steven J. Korzeniewski | 42 | 107 | 5039 |
Edward S. Peters | 31 | 100 | 3754 |
Matthew L. Boulton | 30 | 158 | 5487 |
Glenn Copeland | 29 | 71 | 2828 |
Marion A. Kainer | 28 | 96 | 6210 |
Martin Steinau | 26 | 60 | 2883 |
Lori A. Post | 26 | 94 | 2483 |
Ann P. Rafferty | 23 | 59 | 2379 |
Julia J. Wirth | 22 | 47 | 1743 |
Linda L. Wotring | 22 | 75 | 1569 |
Frances P. Downes | 21 | 31 | 3204 |